Consequently, regular consumption of caffeine in the form of tea or coffee may be a convenient and feasible method to treat RCC patients whose cells show high G6PDH activity, although the clinical application of such an approach needs further verification. The gene discussed is H6PD; the disease is renal cell carcinoma.